Dianthus Therapeutics (DNTH) Non-cash Items (2017 - 2025)

Dianthus Therapeutics' Non-cash Items history runs 6 years deep, the most recent figure standing at $127.5 million for Q4 2025.

• In Q4 2025, Non-cash Items rose 412.92% year-over-year to $127.5 million; the TTM figure through Dec 2025 stood at $127.5 million (up 412.92% YoY), while the FY2025 annual figure was $127.5 million, up 412.92% from the prior year.
• Non-cash Items was $127.5 million for Q4 2025 at Dianthus Therapeutics, up from $2.3 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $127.5 million in Q4 2025 to a low of $776110.0 in Q1 2024.
• Historically, Non-cash Items has averaged $17.1 million across 4 years, with a median of $2.3 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Non-cash Items sank 83.88% in 2024, then surged 1407.7% in 2025.
• A 4-year view of Non-cash Items shows it stood at $1.7 million in 2022, then jumped by 87.12% to $3.2 million in 2023, then surged by 681.74% to $24.9 million in 2024, then soared by 412.92% to $127.5 million in 2025.
• The last three Non-cash Items figures came in at $127.5 million (Q4 2025), $2.3 million (Q3 2025), and $15.5 million (Q2 2025), per Business Quant data.